Form D · Other
Standard Dental Labs Inc.
Orlando, FL · CIK 0001178660
Offering snapshot reported Nov 12, 2025 · SEC filing
- Reported sold
- $118K Offering amount: $750K
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 30, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 12, 2025 | Initial | $117,501 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-563757
Total amount remaining to be sold represents maximum potential exercise price of warrants.
Unit offering; each unit consists of 1 common share and 1 common share purchase warrant, each warrant exercisable at $0.35 per share for subscribers that procure up to 400,000 Units or $0.25 per share for subscribers that procure 400,001 or more units.
Source: Form D, filed Nov 12, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Claire Ambrosio | Director |
| James Brooks | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
424 E. Central Blvd., Suite 308
Orlando, FL, 32801
Orlando, FL, 32801